Unknown

Dataset Information

Severe Acute Kidney Injury and Mortality in Extremely Low Gestational Age Neonates.


ABSTRACT:

Background and objectives

AKI is associated with poor short- and long-term outcomes. Questions remain about the frequency and timing of AKI, and whether AKI is a cause of death in extremely low gestational age neonates.

Design, setting, participants, & measurements

The Recombinant Erythropoietin for Protection of Infant Kidney Disease Study examines the kidney outcomes of extremely low gestational age neonates enrolled in the Preterm Epo Neuroprotection study, a randomized, placebo-controlled trial of recombinant human erythropoietin. We included 900 of 941 patients enrolled in Preterm Epo Neuroprotection. Baseline characteristics were compared by primary exposure (severe AKI versus none/stage 1 AKI) using unadjusted logistic regression models. Cox regression models estimate

SUBMITTER: Hingorani S 

PROVIDER: S-EPMC8216626 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature